Truth for Health Foundation™ is the Trade Name registered with the State of Arizona in 2021 (click here to view the Arizona certificate) for the original 501(c)(3) public charity incorporated in Arizona in 2007 under the name Straight Truth About Hormones Foundation, Inc. The Foundation was conditionally approved by the IRS as a non-profit in 2007, and the Foundation received its full IRS approval as a tax-exempt public charity January 19, 2008, EIN 20-8961711. (click here to view the IRS approval letter). The IRS regulations require that name changes be filed with IRS as part of the next Form 990 following the name change.  Form 990 for 2021 will be filed on schedule in May 2022, and will include the name change registered with the State of Arizona in 2021 when the original Foundation was re-activated and services expanded.


We envision a world where people choose their path to live fully as human beings according to the physical and spiritual laws of life as God designed us.


To provide truthful, balanced, medically sound, research-based information and cutting edge updates on prevention and treatment of common medical conditions, including COVID-19 and other infectious diseases, that affect health, quality of life and longevity.

To present faith-based integrated approaches to medical treatment, health and healing services that encompass all dimensions making us human: physical, psychological/emotional, spiritual, social and environmental.


Truth for Health Foundation is a physician-founded 501(c)3 public charitable Foundation incorporated in the state of Arizona, USA. We are dedicated to following the Oath of Hippocrates to serve individual patients to the best of our ability and judgement and to uphold the highest standards of medical ethics.

Foundation Officers, Directors, and Staff are grounded in Judeo-Christian principles of honesty, integrity, respect, kindness, compassion, humility and commitment to preserving God’s gift of Life as we serve our patients and communities.

We strive to honor God and Jesus Christ in all we do as we conduct business, and to follow Biblical principles exemplified in Jesus’ Healing Ministry throughout the New Testament as we implement health programs for the people we serve.

We are a Christian organization serving people of all faiths, as well as those who do not follow a faith tradition.


 President and Chief Executive Officer:

Dr. Elizabeth Lee Vliet, MD Dr. Vliet has been a leader in patient centered, individualized medical care. Since 1986, she has practiced medicine independent of insurance contracts that interfere with patient-physician relationships and decision-making. Dr. Vliet is the founder of Vive Life Center with medical practices in Tucson AZ and Dallas TX, specializing in preventive and climacteric medicine with an integrated approach to evaluation and treatment of women and men with complex medical and hormonal problems from puberty to late life.  Dr. Vliet is a 2014 Ellis Island Medal of Honor recipient for her national and international educational efforts in health, wellness, and endocrine aging in men and women. She is the creator and host of the new daily talk radio show, Truth for Health…The Rest of the Story, available on all podcast networks.

Since February 2020, Dr. Vliet has been part of the team of frontline physicians treating COVID early and at home to reduce hospitalizations and death. She is a co-author/editor of COVID Early Treatment Guide: Options to Stay Out of Hospital and Save Your Life.

Dr. Vliet’s consumer health books include: It’s My Ovaries, Stupid; Screaming To Be Heard: Hormonal Connections Women Suspect– And Doctors STILL  Ignore; Women, Weight and Hormones; The Savvy Woman’s Guide to PCOS; and The Savvy Woman’s Guide to Great Sex, Strength, and Stamina.

Dr. Vliet is the recipient of the 2007 Voice of Women Award from Arizona Foundation for Women in recognition of her pioneering advocacy for the overlooked hormone connections in women’s health. She is recognized as a powerful patient advocate, motivational speaker in health and wellness, and proponent of free market approaches to lower healthcare costs.  She is a member of the International Menopause Society, the International Society of Gynecological Endocrinology, and the International Society for The Study of the Aging Male (ISSAM). Dr. Vliet is a past Director of the Association of American Physicians and Surgeons (AAPS), and a member of the AAPS Editorial Writing Team.

Prior to leaving academic medicine for independent medical practice, Dr. Vliet was formerly Assistant Professor with joint appointments in Internal Medicine, Family Medicine and Psychiatry at the University of Kansas School of Medicine-Wichita; Assistant Professor at Eastern Virginia Medical School, and Director of Family Medicine Behavioral Medicine (Mind-Body Medicine) program with joint appointments in Family Medicine and Psychiatry/Behavioral Medicine; and Adjunct Assistant Professor at University of North Texas.

She received her M.D. degree and Internal Medicine training at Eastern Virginia Medical School and further specialty training in Behavioral Medicine/Psychiatry at Johns Hopkins.  She earned her B.S. and Master’s degrees from the College of William and Mary in Virginia. 

Dr. Vliet has appeared in many national TV and radio shows across the country and has presented hundreds of professional CME programs for physicians and allied health professionals, as well as healthcare Town Halls, and consumer seminars and radio shows on integrated approaches to Men’s Health and Women’s Health. Dr. Vliet has no financial ties to any health care system, health insurance plan, political party or government agency.  Her allegiance and advocacy is to and for patients.

Chief Medical Advisor:

Dr. Peter McCullough, MD, PhD, FACC, FAHA, FASN, FNKF, FNLA, FCRSA: An internist, cardiologist, and epidemiologist. He maintains ABIM certification in internal medicine and cardiovascular diseases. He practices both internal medicine including the management of common infectious diseases as well as the cardiovascular complications of both the viral infection and the injuries developing after the COVID-19 vaccine in Dallas TX, USA.

Since the outset of the pandemic, Dr. McCullough has been a leader in the medical response to the COVID-19 disaster and has published “Pathophysiological Basis and Rationale for Early Outpatient Treatment of SARS-CoV-2 (COVID-19) Infection” the first synthesis of sequenced multidrug treatment of ambulatory patients infected with SARS-CoV-2 in the American Journal of Medicine and subsequently updated in Reviews in Cardiovascular Medicine. He has 46 peer-reviewed publications on the infection and has commented extensively on the medical response to the COVID-19 crisis in TheHill and on FOX NEWS Channel.

On November 19, 2020, Dr. McCullough testified in the US Senate Committee on Homeland Security and Governmental Affairs and throughout 2021 in the Texas Senate Committee on Health and Human Services, Colorado General Assembly, and New Hampshire Senate concerning many aspects of the pandemic response.

Dr. McCullough has had 18 months of dedicated academic and clinical efforts in combating the SARS-CoV-2 virus and addresssing medical complications and risks of the experimental COVID shots. He has reviewed thousands of reports, participated in many scientific congresses, group discussions, press releases, and has conducted hundreds of educational programs for health professionals and consumers world-wide since the pandemic began. Dr. McCullough is considered among the world’s experts on COVID-19.

Dr. McCullough continues to be a dominant voice in the media across the US and worldwide speaking on early treatment and vaccine risks.

Listen to Dr. McCullough’s weekly medical update radio show, The McCullough Report, on America Out Loud Talk Radio, and archived on Truth For Health Foundation website under Blogs and Podcasts.

Director of Evidence-Based Medicine and Research Methodology:

Dr. Paul E. Alexander, PhD is former Assistant Professor at Canada’s McMaster University in evidence-based medicine. Dr. Alexander served as COVID Pandemic advisor to WHO-PAHO (2020), and as senior advisor to COVID Pandemic policy for the U.S. Department of Health and Human Services (HHS). He is an academic scientist and consultant with expertise in clinical epidemiology, evidence-based medicine and research methodology. Dr. Alexander was appointed in 2008 at WHO as a regional specialist/ epidemiologist in Europe’s Regional office in Denmark (working with Russia, Turkey, Ukraine and Poland). He additionally worked for the government of Canada as an epidemiologist for 12 years, appointed as the Canadian in-field epidemiologist (2002-2004) as part of an international CIDA-funded project on tuberculosis (TB) / HIV co-infection and MDR-TB control executed by Health Canada (involving India, Pakistan, Nepal, Sri Lanka, Bangladesh, Bhutan, Maldives, Afghanistan).

Dr. Alexander was employed from 2017 to 2019 at the Infectious Diseases Society of America (IDSA) as the evidence synthesis meta-analysis systematic review guideline development lead/trainer. He worked with Dr. Donald Henderson, who headed eradication of smallpox and was awarded The Governor General Medal of Canada for academics.

Dr. Alexander completed graduate studies at University of Oxford England, University of Toronto Canada, McMaster University Canada, and York University Canada. His doctoral studies and post doc were completed under supervision of Dr. Gordon Guyatt, co-founder with Dr. Dave Sackett of the field of evidence-based medicine (EBM).’ He completed a certificate program at Johns Hopkins Baltimore, USA in bioterrorism, with a focus on the medical and public health aspects in the event of a deployment of a biological weapon (weaponized pathogen such as smallpox, plague, botulism, tularemia etc.) on a city such as Baltimore.

Biotechnology and Vaccine Advisor:

Alan Moy, M.D. Dr. Moy founded the John Paul II Stem Cell Research Institute (later renamed the John Paul II Medical Research Institute), a tax-exempt 501(c)(3) non-profit research institute devoted to the use of adult stem cells for treating orphan diseases, degenerative neurological diseases, regenerative medicine and cancer.

Dr. Moy is also the co-founder of Cellular Engineering Technologies (CET), a pro-life biotech company that manufactures and sells commercial adult stem cells around the globe. Dr. Moy’s organizations develop biotechnologies with the objective to offer alternative and ethical human cells to embryonic stem cells and aborted fetal cells which are ubiquitously used in the pharmaceutical industry for the production of biologics, gene therapy, cell therapy and vaccines.

Dr. Moy earned his M.D. degree from Creighton University following his undergraduate degree in biochemistry from the University of California at Davis. He completed specialty medical training in Internal Medicine at St. Louis University followed by subspecialty training in pulmonary and critical care at the University of Iowa.  Dr. Moy was faculty between 1994-2005 and tenured in the Department of Medicine and the Department of Biomedical Engineering at the University of Iowa.  Dr. Moy currently maintains an adjunct appointment in the College of Engineering at the University of Iowa.  Dr. Moy’s research at the University of Iowa was in the area of vascular biology, inflammation, gene delivery and tissue engineering.  His research was supported by the National Institute of Health, the American Heart Association, the American Diabetes Association, and the American Lung Association. 

In 2009 the Small Business Commerce Association selected CET among the Best Business Award in the commercial biotechnology category, which recognizes the top 5 percent of small businesses throughout the country.  He has been recognized in the Who’s Who in America and in the Leading Physicians of the World by the International Association of Healthcare Professionals.

Maternal-Fetal Medicine Advisor:

— Richard Blumrick, MD, FACOG. Dr. Blumrick is a Duke fellowship-trained Maternal Fetal Medicine specialist who did his fellowship research on the use of lipid coatings to increase transport across the placenta, and has direct research experience to understand the risks of the lipid-coated experimental gene therapy COVID shots for developing babies when pregnant women are vaccinated.

Dr. Blumrick He is currently Chairman of Obstetrics at a major hospital in a large southwestern city where he has practiced Maternal-Fetal Medicine for 20 years. Dr. Blumrick specializes in treating women who have medical conditions who then become pregnant, and assessing the effects on the baby that can arise from the medical diseases or the drugs used to treat them, as well as healthy women who develop medical complications while pregnant. He evaluates fetal well being throughout the pregnancy, including detailed ultrasounds, fetal dopplers, fetal heart monitoring, and amniocentesis.

He received his MD degree from Columbia University Med School in New York, then completed his OB/GYN specialty residency at St Luke’s/Roosevelt Hospitals, NYC. His Fellowship in Maternal Fetal Medicine was at Duke University.

Reproductive Immunology Advisor:

— Raphael Stricker, MD. Dr. Ray Stricker is currently Medical Director of the Alan E. Beer Medical Center for Reproductive Immunology in Los Gatos, CA, and Union Square Medical Associates, a multispecialty medical practice in San Francisco.

Dr. Stricker is a member of the American Society for Reproductive Immunology (ASRI), the American Federation for Medical Research (AFMR), the American Society of Microbiology (ASM) and the American Society of Hematology (ASH). He is the recipient of the American Medical Association Award for Physician Excellence and an Outstanding Reviewer Award from the Annals of Internal Medicine, and has authored over 200 medical journal articles, letters and abstracts. His research interests include immunological abortion, tickborne diseases and COVID-19.

Dr. Stricker received his medical degree and specialty training in Internal Medicine from Columbia University in New York, NY. He did subspecialty training in Immunology and Immunotherapy at California Pacific Medical Center in San Francisco, CA.

Dr. Stricker is past President of the International Lyme and Associated Diseases Society (ILADS) and a current board member of He also serves on the Lyme Disease Advisory Committee that advises the California Department of Public Health. He has testified at Lyme disease hearings before the California State Senate and the United States Congress.

Internal Medicine Advisor:

Harpal Mangat, M.D. is an independent physician practicing medicine in the greater Washington, D.C. area. Dr. Mangat is an innovator and leader in COVID-19 early treatment who has personally treated over 200 high risk COVID patients early in the home setting, and has taught over 600 physicians the successful multi-drug sequenced early treatment approaches that have kept patients out of the hospital and dramatically reduced risk of dying from COVID. Dr. Mangat has a worldwide reach with dignitaries across the globe and with his wife, has been integrally involved in the Maryland antibody infusion program.

Dr. Mangat attended the Medical School of the Royal College of Surgeons in Ireland, trained at the Trinity College teaching hospitals in family Medicine and ophthalmology before moving the US. He did an Internal medicine  residency in West Philadelphia’s Mercy Medical Center before entering an ophthalmology residency at the University of South Florida. His medical practice in the Washington DC area is focused on challenging cases, with a special interest in neurological Lyme disease complications, and neurological complications of COVID illness and the neurological complications of the experimental genetic COVID shots .

Dr. Mangat is an Assistant professor at Howard University College of Medicine, and also teaches Nurse Practitioner students in the University of Maryland program. Dr. Mangat has 4 issued patents and teaches innovation to University of Maryland biomedical engineering undergraduates. He continues his work educating other physicians on the early treatment of COVID with small group zoom tutorials for healthcare professionals.

Surgery and Family Medicine Advisor:

—Dr./Sister Deirdre Byrne, MD, POSC (Sr. Dede) is a religious sister of the Little Workers of the Sacred Hearts. Many of us came to meet Sr. Dede with her amazing speech at the Republican National Convention in August of 2020. See Sister’s speech HERE.

Sr. Dede is a retired colonel in the U.S. Army Medical Corps after 29 years of service to our country. As an Army and missionary surgeon, she has performed surgery on the ground after natural and man-made crises in Kenya, Afghanistan, Haiti, Iraq and Sudan.

Over the years, Sister Deirdre has found it easy to integrate her medical and military service into her religious vocation. Though comfortable in scrubs, she wears a full black or a white working habit when she can and is grateful for the impact it has on those to whom she ministers. Currently, she is the superior of the D.C. Little Workers of the Sacred Hearts house near Catholic University, where the sisters run a pro-bono physical therapy clinic and diabetic eye clinic, retirement home for her elderly sisters as well as a music school pre-school children.

Sister DeDe’s other charitable medical/surgical service includes hands-on ministry in the rubble of the twin towers following the terrorist attack on 9-11, caring for the sick during the earthquake in Haiti in 2011 and annual medical missions to Haiti and Iraq.

Dentistry and Periodontology Advisor:

—Dr. Howard Tenenbaum DDS, Dip Perio, PhD, FRCD(C)

Dr. Tenenbaum received his D.D.S. from the University of Toronto in 1978 and then completed his specialty in Periodontology as well as a Ph.D. in bone cell biology by 1982.  This was followed by a 2-year post-doctoral MRC fellowship in Bethesda at the National Institutes of Health.  In addition to his degrees, Dr. Tenenbaum has a Fellowship from the Royal College of Dentists of Canada, as well as the International College of Dentists and the Academy of Dentistry International.

Dr. Tenenbaum is a Professor of Periodontology, and was Head of that Discipline for 8 years (1997-2005), at the Faculty of Dentistry, University of Toronto. Dr. Tenebaum is also a Professor in the Department of Laboratory Medicine and Pathophysiology, Faculty of Medicine, University of Toronto. Dr. Tenebaum was also Associate Dean for Biological and Diagnostic Sciences for 6 years.  He served as an FDA panel member for Dental Devices and Drugs (USA) and served as Vice-Chair of the Federal Dental Care Advisory Committee (Canada). 

Dr. Tenebaum is currently Dentist-in-Chief at Mount Sinai Hospital/Sinai Health System, and was the Head of the Division of Research in the Department of Dentistry at Mount Sinai Hospital. He is also an adjunct professor of Periodontology at Tel Aviv University, Israel.

Dr. Tenenbaum has had cumulative peer-reviewed research funding since 1987 exceeding $2.0 million and has lectured internationally on topics including orofacial pain, cellular biology of bone, and management of refractory periodontal diseases.  He a set of experiments carried out aboard the US Space Shuttle by Astronaut/ Senator John Glenn relating to the effects of microgravity of bone cell metabolism and bone formation in culture.  Dr. Tenenbaum has published over 200 peer review and abstracted papers.

Medical Pathology Advisor:

Dr. Roger Hodkinson, MA, MB, B.Chir. (Cantab), FACP, FRCPC.
Dr Hodkinson is a medical specialist in pathology and graduate of Cambridge University who has practiced medicine in the UK, Canada and the US. He is a Fellow of the College of American Pathologists and the Royal College of Physicians and Surgeons of Canada. During his long career he has had many leadership roles in Canadian medicine both provincially and nationally, including being a university teacher, national pathology board examiner, and laboratory accreditation inspector. He was previously the President of the Alberta Society of Laboratory Physicians, an Assistant Professor in the Faculty of Medicine at the University of Alberta, and CEO of a large community based medical laboratory with a full menu of testing for infectious disease and virology.

Dr. Hodkinson is currently the Chairman of an American biotechnology company active in DNA sequencing. But he is most proud of his role for many years in public health advocacy as Honorary Chairman of ASH, Action on Smoking and Health, which is the leading non-profit organization in Canada tackling the predatory marketing strategies of Big Tobacco, and for which he was made Citizen of the Year in Edmonton, Alberta.


Original incorporation name: Straight Truth About Hormones Foundation, Inc. dba: Truth For Health Foundation 

IRS Exemption Letter effective date: April 20, 2007.

Founding Director and President: Elizabeth Lee Vliet, MD                

Founding Director: Gordon Cheesman Vliet

Current Officers:  Elizabeth Lee Vliet, M.D. – President and CEO

         J. Thomas (Tom) Wadkins, III – Vice President, Operations

Consulting Executive Director:

Nancy Dean is the Founder and President of Philanthropy A-Z.  Philanthropy A-Z is a full-service consulting practice that connects strategy with subject matter expertise to create dynamic solutions for purpose-driven organizations.  In addition to United Way, Nancy is working with other national and local organizations as well as providing executive coaching.   Always mission-driven and passionate about helping individuals and communities flourish, her career spans geography and areas of focus.  She brings significant executive presence through her experience in diverse C-Suite roles with organizations such as the American Red Cross, United Way, and the Arizona Foundation for Women, where she served as President and Chief Executive Officer. 

Before launching Philanthropy A-Z, she served in multiple leadership roles with Valley of the Sun United Way over 10 years.  Nancy held multiple executive positions including responsibility for resource development, volunteer engagement, strategy, innovation, and community impact.  She also has worked on numerous United Way Worldwide initiatives; including leading a cross-market team on culture, innovation and individual engagement.  Nancy is a seasoned development executive, gaining much of her experience from executive roles in higher education development, alumni and community relations.  She has worked for the University of Nevada, Reno as well as Arizona State University, and the Arizona State University Foundation. Her development experience spans annual giving to major gifts and capital campaigns. Prior to her work in higher education, Nancy administered volunteer programs at two large healthcare organizations in California and Nevada. She holds degrees from the University of California, Irvine and the University of Southern California. 

Foundation Contacts: Voice 520-777-7092  Fax 520-797-2948

Mailing Address: P.O. Box 64507 Tucson, AZ 85728